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OBJECTIVE—Accumulating evidence has identiﬁed a positive association between active
smoking and the risk of diabetes, but previous studies had limited information on passive
smoking or changes in smoking behaviors over time. This analysis examined the association
between exposure to passive smoke, active smoking, and the risk of incident type 2 diabetes
among women.
RESEARCH DESIGN AND METHODS—This is a prospective cohort study of 100,526
womenintheNurses’HealthStudywhodidnothaveprevalentdiabetesin1982,with follow-up
for diabetes for 24 years.
RESULTS—Weidentiﬁed5,392incidentcasesoftype2diabetesduring24yearsoffollow-up.
Compared with nonsmokers with no exposure to passive smoke, there was an increased risk of
diabetesamongnonsmokerswhowereoccasionally(relativerisk[RR]1.10[95%CI0.94–1.23])
or regularly (1.16 [1.00–1.35]) exposed to passive smoke. The risk of incident type 2 diabetes
was increased by 28% (12–50) among all past smokers. The risk diminished as time since
quitting increased but still was elevated even 20–29 years later (1.15 [1.00–1.32]). Current
smokers had the highest risk of incident type 2 diabetes in a dose-dependent manner. Adjusted
RRs increased from 1.39 (1.17–1.64) for 1–14 cigarettes per day to 1.98 (1.57–2.36) for $25
cigarettes per day compared with nonsmokers with no exposure to passive smoke.
CONCLUSIONS—Ourstudysuggeststhatexposuretopassivesmokeandactivesmokingare
positively and independently associated with the risk of type 2 diabetes.
Diabetes Care 34:892–897, 2011
S
moking is one of the leading causes
of avoidable death globally (1). The
disease burden attributable to
smoking already is enormous, with ~6
million premature deaths worldwide
each year, and is projected to grow sub-
stantially across the century without an
end to the pandemic (1). Diabetes also
is a global health priority. The Interna-
tional Diabetes Federation has predicted
that the number of individuals with dia-
betes will increase from 240 million in
2007 to 380 million in 2025 (2).
Accumulating evidence has identiﬁed
a positive association between active
smoking and risk of type 2 diabetes (3),
whereas few studies had information on
passive smoking. Data from the Third
National Health and Nutrition Examina-
tion Survey 1988–1991 suggest that
~90% of nonsmokers have detectable
levels ofserumcotinine,asensitivemarker
for tobacco exposure (4). Therefore, pre-
vious studies linking active smoking with
diabetes risk might have underestimated
the magnitude of the true association be-
cause individuals exposed to passive
smoke would be in the reference group.
Thefewstudiesthatsimultaneouslyexam-
ined the relative associations of passive
and active smoking on diabetes risk (5,6)
were limited by relatively short follow-up
periods, limited information on potential
confounders, and lack of information on
smoking quantity or change in smoking
behavior over time. Therefore, we pro-
spectively investigated the association be-
tween passive and active smoking and the
risk of incident type 2 diabetes over 24
years of follow-up among 100,526
women from the Nurses’ Health Study
(NHS).
RESEARCH DESIGN AND
METHODS—The NHS is an ongoing
prospective cohort study of 121,700
registered nurses that began in 1976.
Participants are followed via biennial ques-
tionnairestoupdateinformationonhealth-
related behaviors and medical events. The
follow-up for the cohort exceeded 90%
through2006.Thisstudywasapprovedby
the institutional review board at Brigham
and Women’s Hospital.
The studypopulationforthisanalysis
comprised 100,526 participants of the
NHS who did not have prevalent diabetes
or cancer (except for nonmelanoma skin
cancer) in 1982 when passive smoking
was ﬁrst assessed.
Assessment of status of smoking
The initial NHS questionnaire (1976)
inquired of regular smokers at what age
smoking began and the average quantity
of cigarettes smoked per day. With each
subsequent biennial questionnaire, par-
ticipants reported whether they were
current smokers. The intensity of smok-
ing among current smokers was assessed
by self-reported number of cigarettes per
day in six categories (1–4, 5–14, 15–24,
25–34, 35–44, or $45). In the 1982
questionnaire (baseline of the present
study), participants were asked, “Are
you currently exposed to cigarette smoke
from other people?” Responses were cat-
egorized into three levels: no exposure,
occasional exposure, and regular expo-
sure. Although we do not have direct val-
idation of self-reported passive smoke
e x p o s u r e ,w eh a v ep r e v i o u s l yr e p o r t e d
that these women had higher toenail
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w h or e p o r t e dn oe x p o s u r et op a s s i v e
smoke (7).
Duration of smoking and years since
quitting were calculated based on informa-
tion from the initial and subsequent ques-
tionnaires. Pack-years of smoking (the
equivalent of smoking 20 cigarettes a day
for 1 year) was calculated by multiplying
thenumberofpackssmokedperdaybythe
number of years of smoking.
Assessment of other covariates
Information on race, family history of
diabetes, and waist circumference was
obtained at baseline. BMI (calculated as
weightinkilogramsdividedbythesquare
of height in meters) and physical activity
(metabolic equivalent tasks) were ascer-
tained at baseline and updated with new
information every 2 years. Total energy
intake and intakes of alcohol, magne-
sium, calcium, vitamin D, total trans fat,
ﬁber from cereal, and caffeine were ascer-
tained ﬁrst in 1980 using a semiquantita-
tive food frequency questionnaire (FFQ)
a n dt h e nu p d a t e de v e r y2 –4 years from
subsequent FFQs. The reproducibility
and validity of the FFQ in the NHS has
beendocumented(8).Exceptfortotalen-
ergyintakeandintakeofalcohol,nutrient
values were adjusted for total energy
intake by the residual method (9). Hus-
band’s education status, which was in-
quired in 1992, also was included in the
analyses as an indicator of socioeco-
nomic status because of the limited
variability in the nurses’ education at-
tainment.
Assessment of diabetes
Thebaselineandbiennialfollow-upques-
tionnaires asked participants to report
whether a clinician had made a new
diagnosis of type 2 diabetes during the
preceding 2 years. Women who self-
reported diabetes were then sent a sup-
plementary questionnaire to conﬁrm the
diagnosis of diabetes; this questionnaire
gathered information about symptoms,
diagnostic laboratory test results, and di-
abetes treatment (10). Diagnosis of diabe-
tes by the supplementary questionnaire in
the NHS has been shown to be highly ac-
curate (98.4% were conﬁrmed by medical
records), with a low percentage of false-
negative self-reports (0.5%) (11).
Statistical analyses
Person-time was censored at the date of
diabetes diagnosis, death, incident cancer
diagnosis (except for nonmelanoma skin
cancer), or the end of follow-up (June
2006), whichever came ﬁrst. Participants
whodidnotreturnthebaselineFFQwere
allowed to contribute person-time for
later time intervals if they returned a sub-
sequent FFQ.
In our primary analysis, participants
were classiﬁed by smoking status at base-
line (1982) and reclassiﬁed in each bi-
ennial follow-up cycle. Smoking status
was analyzed in seven groups: 1) partici-
pants who were consistent nonsmokers
through June 2006 and who reported
no exposure to passive smoke (which
was the reference group); 2) participants
whowerepersistentnonsmokersthrough
June 2006 but who occasionally were ex-
posed to passive smoke; 3)p a r t i c i p a n t s
whowerepersistentnonsmokersthrough
June 2006 but who were regularly ex-
posed to passive smoke; 4)p a s ts m o k e r s ;
5) current smokers who smoked 1–14
cigarettes per day; 6)c u r r e n ts m o k e r s
who smoked 15–24 cigarettes per day;
and 7) current smokers who smoked
$25 cigarettes per day. Exposure to pas-
sive smoke at baseline was carried for-
ward in subsequent time intervals.
Participantswhoneverprovidedinforma-
tion on exposure to passive smoke and
active smoking (9.5%) were included in
the analysis as a separate missing group.
Cox proportional hazards regression
models were used to estimate relative
risks (RRs) and 95% CIs. Multivariable
models were constructedtoadjustforpo-
tential confounding variables that have
been previously associated with incident
diabetes (age [continuous], race [Cauca-
sian, American African, American Indian,
and other], BMI [continuous], quadratic
BMI [continuous], physical activity
[quintiles], husband’s education status
[high school or less, Bachelor’s degree,
or higher than Bachelor’s degree], family
history of diabetes [yes or no], total en-
ergy intake [in quintiles], and intakes of
alcohol [six categories], magnesium, cal-
cium, vitamin D, total trans fat, ﬁber from
cereal and caffeine, total fat and saturated
fat[allinquintiles]).Proportionalhazards
assumptions were veriﬁed by testing the
interaction with time using the likelihood
ratio test (P = 0.27).
We also performed four additional
analyses. First, to address the possibility
of confounding by other markers of
adiposity, we added baseline waist cir-
cumstance to the multivariable Cox pro-
portional hazards regression model.
Second, we analyzed the association be-
tween active smoking and diabetes using
pack-years (in place of cigarettes per day)
in the following categories: 1–9, 10–19,
20–29, 30–39, and $40 pack-years.
Third, we divided past smokers into ﬁve
groups based on the number of years
since quitting (,5, 5–9, 10–19, 20–29,
and $30 years), in order to assess cessa-
tion of active smoking on the risk of di-
abetes. Finally, to compare the results of
our study more closely with the results
reported by other investigators, we ana-
lyzed the association between active
smoking and incident diabetes after rede-
ﬁning the reference group to include all
nonsmokers (combining nonsmokers
without passive smoke exposure and
nonsmokerswhowereexposedtopassive
smoke); this reference group is more sim-
ilar to the reference groups in most pre-
vious studies. All P values are two-tailed.
Statistical tests were performed using SAS
version 9.1 for Unix statistical software
package (SAS Institute, Cary, NC).
RESULTS—During 24 years (1,539,278
person-years) of follow-up, 5,392 inci-
dent cases of physician-diagnosed type 2
diabetes were conﬁrmed with the supple-
mentary questionnaire. Participant charac-
teristics by status of smoking are presented
in Table 1. Compared with nonsmokers
without exposure to passive smoke,
women exposed to passive smoke had
higher BMIs, were less physically active,
were more likely to be Caucasian, were
more likely to have a family history of di-
abetes, and were less likely to have a hus-
bandwithaBachelor’sdegreeorhigher.In
contrast, BMI values were similar among
current smokersandnonsmokers without
exposure to passive smoke. The percent-
age of women with a positive family his-
tory of diabetes was lower among current
smokers compared with nonsmokers
without exposure to passive smoke. Cur-
rent smokers also tended to have a lower
intake of calcium and vitamin D and a
higher intake of alcohol and caffeine.
Active and passive smoking were
positively associated with the risk of in-
cident type 2 diabetes (Table 2). Com-
pared with nonsmokers without passive
smoke exposure, the multivariable-
adjusted RRs for nonsmoking women
whowereoccasionallyorregularlyexposed
topassivesmokewere1.10(95%CI0.94–
1.23) and 1.16 (1.00–1.35), respectively.
The risk of incident type 2 diabetes was
increased by 28% (12–50) among past
smokers.Currentsmokershadthehighest
risk of incident type 2 diabetes in a dose-
dependent manner (P value for trend
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Zhang and Associates,0.001). For women who currently
smoked $25 cigarettes per day, the risk
of type 2 diabetes was increased by nearly
twofold(RR1.98[1.57–2.36]).Additional
adjustment for waist circumference did
not materially alter the results.
We also observed a dose-dependent
association between active smoking and
diabetes risk when cumulative pack-years
were analyzed (Table 3). For participants
with 1–9 pack-years of smoking, the ad-
justed RR for diabetes was 1.17 (95% CI
1.01–1.35) compared with nonsmokers
with no exposure to passive smoke. The
RR increased gradually across the catego-
ries and was 1.72 (1.48–1.98) for partic-
ipants with $40 pack-years of smoking
(P value for trend ,0.001).
The risk of diabetes decreased grad-
ually as the time since quitting increased
(Table 3; P value for trend ,0.001). For
those who only recently quit (,5 years of
abstinence), the risk remained high com-
pared with nonsmokers without expo-
sure to passive smoke (RR 1.88 [95% CI
1.59–2.23]). The RR decreased over time
but still was elevated 20–29 years later
(1.15 [1.00–1.32]). By the time 30 years
had passed since quitting, the association
was no longer signiﬁcant (1.06 [0.90–
1.24]).
Inthesecondaryanalysisinwhichthe
reference group was redeﬁned to include
all nonsmokers, the multivariable RR was
1.16 (95% CI 1.09–1.25) for past smok-
ers and 1.50 (1.35–1.66) for current
smokers. Among current smokers, the
risk of type 2 diabetes increased from
1.29 (1.12–1.50) for women who
smoked 1–14 cigarettes per day to 1.86
(1.56–2.20) for women who smoked
$25 cigarettes per day.
CONCLUSIONS—In our prospective
study of 100,526 women followed for 24
years, we found that exposure to passive
smoke and active smoking were indepen-
dently associated with the risk of devel-
oping type 2 diabetes. The association
appeared dose dependent and remained
signiﬁcant after carefully controlling for
multiple relevant lifestyle and dietary
factors. After quitting, the risk of diabetes
decreased gradually but still was signiﬁ-
cantly elevated 20 years later.
Several mechanisms may be involved
in the increased risk of diabetes among
smokers. First, cigarette smoking has
been related to various systemic effects,
including oxidative stress, systemic in-
ﬂammation, and endothelial dysfunc-
tion, as reviewed by Yanbaeva et al. (12).
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Smoking and diabetesEach of these effects has been strongly
implicated in insulin resistance (13) and
diabetes risk (10,14,15). Second, even
though smokers tend to have a lower
mean BMI compared with nonsmokers,
they have a more metabolically adverse
fat distribution proﬁle, with higher cen-
tral adiposity (16). Finally, smoking
could directly damage b-cell function
(17) or induce chronic pancreatic inﬂam-
mation (18). Those studies provide bio-
logical plausibility for a causal relation
between smoking and diabetes.
There is fairly strong evidence sup-
porting active smoking as a risk factor for
type2diabetes.Arecentmeta-analysis(3)
involving 25 prospective cohort studies
reported a pooled adjusted RR of 1.44
(95% CI 1.31–1.58) for active smoking.
However,ouranalysis,aswellasprevious
studies (4,19), demonstrate that a large
proportion of nonactive smokers (the ref-
erence group used in the recent meta-
analysis [3]) may be exposed to passive
smoke and that these participants are at
increased risk of diabetes compared with
individuals without any active or passive
smoke exposure (5,6). Thus, the pooled
RR of 1.44 reported in the meta-analysis
may be a systematic underestimate of the
true magnitude of the association, which
is supported by our secondary analysis
using all nonsmokers as the reference
group (1.50 [1.35–1.66]). Furthermore,
many of the studies included in the
meta-analysis did not control for certain
important lifestyle and dietary variables,
suchasalcoholintakeand caffeineintake,
which we and others have found to be
important negative confounders in the
association between smoking and risk of
diabetes (20,21). The inability in the meta-
analysis to account for these variables also
would tend to produce an underestimate
of the true association. That meta-analysis
did not include main results from our co-
hort that showed a link between smoking
and diabetes risk; these data, which were
published nearly two decades ago (22),
demonstrated an RR of type 2 diabetes
among women who smoked $25 ciga-
rettes per day compared with nonactive
smokers of 1.49 (1.19–1.87) (22). Al-
though womenfromthat study alsoare in-
cluded in the present analysis, we have
expanded on the approach by taking pas-
sive smoke exposure into account, rigor-
ously analyzing duration since quitting,
adjusting for additional confounders, and
also have 16 additional years of follow-up.
Several longitudinal studies investi-
gated the association of smoking cessation
on the risk of diabetes. Data from the
Cancer Prevention Study suggested that
quitting smoking reduced the rate of di-
abetes to that of nonsmokers after 5 years
in women and after 10 years in men (23).
Updated information of smoking status,
lifestyle, and diet were not available in
that study. Another study among middle-
aged British men (24) indicated that start-
ing from 5 years after smoking cessation,
the risk of type 2 diabetes started to de-
crease compared with current smokers;
however, the risk of diabetes was not
equivalent to the risk among nonsmokers
until 20 years after quitting (24). In our
study,theriskofdiabetesstillwaselevated
20 years after quitting, with an adjusted
RR of 1.18 (95% CI 1.01–1.38). The
same reasons for why the association be-
tween active smoking and diabetes were
stronger in our analysis compared with
the previous meta-analysis also may ex-
plain why a longer duration of quitting
was required for risk equalization in our
study compared with these previous two
studies. Speciﬁcally, these two previous
studies did not exclude passive smokers
from the reference group and did not have
information on all relevant confounders.
Our study has strengths and limita-
tions that deserve mention. A major
strength of this study, aside from its
prospective nature and high follow-up
rate, is the ability to control for various
potential confounders and other known
risk factors of diabetes. Confounding by
time-varying covariates, especially life-
style and dietary variables, is minimized
by updating covariates every 2–4 years.
Our study has limitations as well. For ex-
ample, diabetes was self-reported. How-
ever,alloftheparticipantswereregistered
nurses, and self-reported diabetes was
veriﬁed by a validated supplementary
questionnaire (11). The possibility for re-
sidualconfoundingbyunmeasuredmate-
rial and cultural factors, especially for the
association between passive smoking and
risk of diabetes, cannot be fully elimi-
nated. In addition, our population was
almost entirely white and exclusively fe-
male; thus, our results may not be gener-
alizable to other populations. However,
the relative homogeneity of the cohort in
educational attainment and socioeco-
nomic status actually may serve to en-
hance the internal validity of this study.
Another important limitation was the
way in which we ascertained passive
smoke exposure. First, we relied on self-
reports of passive smoke exposure. Self-
reports of exposure to passive smoke are
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Zhang and Associatesonlymodestlycorrelatedwithbiomarkers
of tobacco-smoke exposure, such as se-
rumcotinine(19,25).Partofthereasonis
theubiquitousnatureofpassivesmoke.A
study of 663 subjects who never used to-
bacco and former tobacco users revealed
that cotinine was found in the urine of
91% of participants, whereas only 76%
reported exposure to passive smoke
(19). Second, our assessment of passive
smoke exposure was ascertained only at
baseline in 1982, and it is likely that ex-
posure to passive smoke changed over
time because of individual factors (e.g.,
retirement) or societal factors (e.g., na-
tional interventions to reduce smoking).
These two limitations would tend to re-
sult in misclassiﬁcation, such that those
women reporting little or no exposure in
1982 actually may have had important
levels of exposure, whereas those report-
ingheavyexposurein1982mayhavehad
less exposure in the later years of follow-
up. This type of misclassiﬁcation would
tendtoproduceweakerRRestimatesthan
would hypothetically be observed in an
ideal study. Therefore, we may have actu-
allyunderestimatedthetruemagnitudeof
the association between exposure to pas-
sive smoke and diabetes.
In conclusion, our prospective anal-
ysis suggests that smoking is strongly and
independently associated with the risk of
incidenttype2diabetesinadose-dependent
manner. Among former active smokers,
the increased risk of diabetes persisted for
20 years after smoking cessation. Previous
studies may have underestimated the
magnitude and duration of the increased
risk of diabetes associated with smoking.
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